Annual report pursuant to Section 13 and 15(d)

Intangible Assets

v3.10.0.1
Intangible Assets
 12 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
Intangible Assets

On December 1, 2015, the Company acquired substantially all of the assets of Equipois, LLC, a New Hampshire limited liability company or Equipois, for an initial payment of approximately $1,100, paid for by issuance of the Company’s common stock pursuant to an asset purchase agreement among the Company, Ekso Bionics, Inc., Equipois and Allard Nazarian Group, Inc. The Company recorded $1,610 to intangible assets as of the acquisition date and has amortized the value of the technology, customer relationships and trade name over an estimated useful life of 3 years.  Amortization expense related to the acquired intangible assets was $491 and $535 for the years ended December 31, 2018 and 2017, respectively, and was included as a component of operating expenses in the consolidated statement of operations and comprehensive loss.

The following table reflects the amortization of the acquired intangible assets as of December 31, 2018:
 
Cost
 
Accumulated
Amortization
 
Net
 
Estimated
Useful Life
Developed technology
$
1,160

 
$
(1,160
)
 
$
—

 
3 years
Customer relationships
70

 
(70
)
 
—

 
3 years
Customer trade name
380

 
(380
)
 
—

 
3 years
 
$
1,610

 
$
(1,610
)
 
$
—